As markets continue to gyrate, some of the island's larger insurers have sought to take advantage while smaller players are struggling with weaker capital positions.
Market volatility has resulted in challenges in both equity and fixed-income investments for China's biggest lifer.
The firm outlined its investment plans and macro outlook, while admitting that the coronavirus epidemic will have near-term impact on its investments as markets will be more volatile.
It has yet to pick its external managers, let alone fulfil its QDII quota, AsianInvestor’s Institutional Investment Forum China heard. 'Why?' is a question with broader ramifications.
China's second-largest life insurer also upped its investments in a selective number of stocks, according to its latest interim results.
The increase in exposure will mainly be driven by heavier co-investments in the region and by adding more country-focused managers.